Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03930121 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 16, 2025 (before its estimated February 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Feb 4, 2025 to Feb 4, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 18 to 19
    • Study completion date: Aug 4, 2025 to Aug 4, 2026
    v9
  2. Primary completion date: Feb 4, 2024 to Feb 4, 2025
    • Study completion date: Aug 4, 2024 to Aug 4, 2025
    v8
  3. Site contacts updated at 1 of 18 sitesv7
  4. Eligibility criteria revisedv6
  5. Primary completion date: Oct 1, 2022 to Feb 4, 2024
    • Study completion date: Mar 31, 2023 to Aug 4, 2024
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Eligibility criteria expanded, about 20 wordsv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2019 to Dec 6, 2019
    • Study sites: 1 to 18
    • Secondary endpoints: details revised at 1 of 11 entries
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to investigate whether intensive speech-language therapy (SLT) combined with anodal transcranial direct current stimulation (tDCS) leads to better communication performance than SLT combined with placebo stimulation (using sham-tDCS).
Trial Details
NCT Number NCT03930121
Lead Sponsor University Medicine Greifswald
Conditions
(from sponsor)		 Aphasia, Post-stroke
Related terms Aphasia
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov